Treatment of Premature Retinopathy with Biosimilar Ranibizumab Seems Effective.

Published Date: 27 Apr 2023

Treatment of Retinopathy of Prematurity with Biosimilar Ranibizumab Seems Effective.

Read Full News

Latest News

Growing Support for Initiatives to Recognize Myopia as a Disease

— Risk of vision-threatening complications of nearsightedness gets attention of AMA, Congress

Eye Pain and Deteriorating Vision After Treatment for Macular Degeneration

Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections

Eyeball Tattoo Goes Sideways

Irritation began after a swim in the Mediterranean

Lost to Follow-Up Predictors in Wet AMD

Travel distance, race/ethnicity, male sex boost odds, may inform adherence strategies

Should Optometry Play a Bigger Role in Wet AMD Monitoring?

Study supports it but ophthalmologist warns against expanding optometry scope of practice

Satralizumab Shows Promise for Thyroid Eye Disease

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Latest News

— Risk of vision-threatening complications of nearsightedness gets attention of AMA, Congress

Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections

Irritation began after a swim in the Mediterranean

Travel distance, race/ethnicity, male sex boost odds, may inform adherence strategies

Study supports it but ophthalmologist warns against expanding optometry scope of practice

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

News All Time

Stem Cell Therapy for GA Shows Early Evidence of Vision Gains, Retina Preservation

ASP7317 may offer potential to improve vision and repair retina, not just slow down atrophy

Use of PDE5 Inhibitor Tied to Increased Glaucoma Risk

Findings add to existing evidence linking the drug class to ophthalmic conditions

Medicare's Paying Less for Cataract Surgery. Ophthalmologists Are Turning to Lasers.

— Doctors typically charge $1,000 to $3,000 per eye for use of the laser

Branded Bevacizumab Approved for Wet AMD

Approval follows 20 years of off-label use of compounded formulations of the VEGF inhibitor

Medicare Is Paying Less for Cataract Surgery

Medicare pays doctors about $520 for a standard cataract procedure, down about 20% in the past decade.

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.